Sensibilidad de la neisseria meningitidis a la rifampicina: estudio durante los años 1984-1986

Rodríguez Rodríguez, José; Medina Rojas, Matilde; Echeverría Rojas, Amada; Torres de la Torre, Maritza.
Medicentro ; 4(2): 330-5, 1988. tab
Artículo en Español | CUMED | ID: cum-17252

Documentos relacionados

  1. Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins.
  2. Atomic-Resolution 1.3 Å Crystal Structure, Inhibition by Sulfate, and Molecular Dynamics of the Bacterial Enzyme DapE.
  3. Biochemical characterization of RNA-guided ribonuclease activities for CRISPR-Cas9 systems.
  4. Broad-spectrum in vitro activity of macrophage infectivity potentiator inhibitors against Gram-negative bacteria and Leishmania major.
  5. Variable disruption of epithelial monolayers by <i>Neisseria meningitidis</i> carriage isolates of the hypervirulent MenW cc11 and MenY cc23 lineages.
  6. Inhibitors of the <i>Neisseria meningitidis</i> PilF ATPase provoke type IV pilus disassembly.
  7. Sodium Tetraphenylborate Displays Selective Bactericidal Activity against Neisseria meningitidis and N. gonorrhoeae and Is Effective at Reducing Bacterial Infection Load.
  8. Optogenetic control of Neisseria meningitidis Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein.
  9. [The sensitivity of a number of cell cultures to different strains of Rickettsia prowazekii].
  10. Meningococcal surface fibril (Msf) binds to activated vitronectin and inhibits the terminal complement pathway to increase serum resistance.